Cargando…

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)

RATIONALE: CSF1R tyrosine kinase inhibitors (TKI) and antibodies yield response rates and tumor control in patients with diffuse type tenosynovial giant cell tumors (dTGCT). The long term management of patients with dTGCT treated with TKI is however not known. PATIENTS AND METHODS: We conducted a re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brahmi, Mehdi, Cassier, Philippe, Dufresne, Armelle, Chabaud, Sylvie, Karanian, Marie, Meurgey, Alexandra, Bouhamama, Amine, Gouin, Francois, Vaz, Gualter, Garret, Jerome, Sunyach, Marie-Pierre, Dupré, Aurélien, Marec-Berard, Perrine, Corradini, Nadège, Perol, David, Ray-Coquard, Isabelle, Blay, Jean-Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239463/ https://www.ncbi.nlm.nih.gov/pubmed/32433669 http://dx.doi.org/10.1371/journal.pone.0233046

Ejemplares similares

Expanding the molecular spectrum of tenosynovial giant cell tumors
por: Gauduchon, Thibault, et al.
Publicado: (2022)

Percutaneous Core Needle Biopsy Can Efficiently and Safely Diagnose Most Primary Bone Tumors
por: Crenn, Vincent, et al.
Publicado: (2021)

Very long‐term survivors among patients with metastatic soft tissue sarcoma
por: Carbonnaux, Mélodie, et al.
Publicado: (2019)

Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection
por: Allignet, Benoît, et al.
Publicado: (2023)

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History
por: Brahmi, Mehdi, et al.
Publicado: (2020)

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
por: Bernthal, Nicholas M., et al.
Publicado: (2021)

Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle—A systematic review and meta-analysis
por: Siegel, M., et al.
Publicado: (2021)

The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)
por: Gelhorn, Heather L., et al.
Publicado: (2019)

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
por: Verspoor, F. G. M., et al.
Publicado: (2019)

One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study
por: Spierenburg, Geert, et al.
Publicado: (2023)

Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families
por: McMaster, Mary L, et al.
Publicado: (2015)

Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings
por: Dufresne, Armelle, et al.
Publicado: (2012)

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors
por: Gelderblom, Hans, et al.
Publicado: (2020)

In Search of TGCT Biomarkers: A Comprehensive In Silico and Histopathological Analysis
por: Raos, Dora, et al.
Publicado: (2020)

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT
por: Tap, William D., et al.
Publicado: (2022)

The utility of cfDNA in TGCT patient management: a systematic review
por: Krasic, Jure, et al.
Publicado: (2022)

Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment
por: Feng, Xiaolan, et al.
Publicado: (2023)

French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
por: Penel, N., et al.
Publicado: (2020)

Refining Prognosis in Localized Gastrointestinal Stromal Tumor: Clinical Significance of Phosphatase and Tensin Homolog Low Expression and Gene Loss
por: Feng, Xiaolan, et al.
Publicado: (2022)

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials
por: Nassif, E.F., et al.
Publicado: (2022)

Erratum to “The utility of cfDNA in TGCT patient management: a systematic review”
Publicado: (2022)

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome
por: Brahmi, Mehdi, et al.
Publicado: (2015)

Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
por: Lewis, James H., et al.
Publicado: (2020)

Options thérapeutiques de prise en charge des sarcomes durant la pandémie COVID-19 : propositions du groupe sarcome français
por: Penel, Nicolas, et al.
Publicado: (2020)

Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients
por: Cuevas-Estrada, Berenice, et al.
Publicado: (2023)

Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network
por: Zhu, Fang, et al.
Publicado: (2021)

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
por: Assaad, Souad, et al.
Publicado: (2020)

Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features
por: Robert, Marie, et al.
Publicado: (2022)

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial
por: Arnaud-Coffin, Patrick, et al.
Publicado: (2020)

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
por: Gutekunst, Matthias, et al.
Publicado: (2011)

Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology
por: Dufresne, Armelle, et al.
Publicado: (2014)

Neonatal Soft Tissue Sarcoma with YWHAE-NUTM2B Fusion
por: Guizard, Maylis, et al.
Publicado: (2019)

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond
por: de Bernardi, Axel, et al.
Publicado: (2022)

Localized tenosynovial giant cell tumor in children
por: Du, Xifeng, et al.
Publicado: (2023)

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC’s)
por: Bétrian, Sarah, et al.
Publicado: (2017)

Surgical management of 144 diffuse‐type TGCT patients in a single institution: A 20‐year cohort study
por: Spierenburg, Geert, et al.
Publicado: (2022)

Dataset of testicular germ cell tumors (TGCT) risk associated with serum polychlorinated biphenyl (PCB) by age at diagnosis and histologic types
por: Cheng, Zhiyuan, et al.
Publicado: (2021)

Tenosynovial Giant Cell Tumor Arising on the Scapular Region
por: Fukuda, Asako, et al.
Publicado: (2013)

Diffuse Type Tenosynovial Giant Cell Tumor of the Ankle
por: Zhao, Jing-Jing, et al.
Publicado: (2016)

Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors
por: Verspoor, F. G. M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ui49ne02uv8falrr2kub32k2ls